197 related articles for article (PubMed ID: 21806316)
1. Emerging drugs for amyotrophic lateral sclerosis.
Habib AA; Mitsumoto H
Expert Opin Emerg Drugs; 2011 Sep; 16(3):537-58. PubMed ID: 21806316
[TBL] [Abstract][Full Text] [Related]
2. Therapy in Amyotrophic Lateral Sclerosis (ALS): an unexpected evolving scenario.
Silani V
Arch Ital Biol; 2017 Dec; 155(4):118-130. PubMed ID: 29405033
[TBL] [Abstract][Full Text] [Related]
3. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG; Mitchell JD; Lyon M; Moore DH
Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
[TBL] [Abstract][Full Text] [Related]
4. Emerging Drugs for the Treatment of Amyotrophic Lateral Sclerosis: A Focus on Recent Phase 2 Trials.
Barp A; Gerardi F; Lizio A; Sansone VA; Lunetta C
Expert Opin Emerg Drugs; 2020 Jun; 25(2):145-164. PubMed ID: 32456491
[TBL] [Abstract][Full Text] [Related]
5. Experimental trials in amyotrophic lateral sclerosis: a review of recently completed, ongoing and planned trials using existing and novel drugs.
Goyal NA; Mozaffar T
Expert Opin Investig Drugs; 2014 Nov; 23(11):1541-51. PubMed ID: 24965719
[TBL] [Abstract][Full Text] [Related]
6. New therapy options for amyotrophic lateral sclerosis.
Gordon P; Corcia P; Meininger V
Expert Opin Pharmacother; 2013 Oct; 14(14):1907-17. PubMed ID: 23855817
[TBL] [Abstract][Full Text] [Related]
7. Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs.
Jaiswal MK
Med Res Rev; 2019 Mar; 39(2):733-748. PubMed ID: 30101496
[TBL] [Abstract][Full Text] [Related]
8. [Amyotrophic lateral sclerosis: update on etiological treatment].
Ayach L; Curti C; Montana M; Pisano P; Vanelle P
Therapie; 2013; 68(2):93-106. PubMed ID: 23773350
[TBL] [Abstract][Full Text] [Related]
9. New therapeutic targets for amyotrophic lateral sclerosis.
Kuzma-Kozakiewicz M; Kwiecinski H
Expert Opin Ther Targets; 2011 Feb; 15(2):127-43. PubMed ID: 21133819
[TBL] [Abstract][Full Text] [Related]
10. Enhancing clinical trials in neurodegenerative disorders: lessons from amyotrophic lateral sclerosis.
Gladman M; Cudkowicz M; Zinman L
Curr Opin Neurol; 2012 Dec; 25(6):735-42. PubMed ID: 23160423
[TBL] [Abstract][Full Text] [Related]
11. Clinical trials in ALS: what did we learn from recent trials in humans?
Meininger V
Neurodegener Dis; 2005; 2(3-4):208-14. PubMed ID: 16909027
[TBL] [Abstract][Full Text] [Related]
12. [Cotreatment of amyotrophic lateral sclerosis patients].
Iwasaki Y; Ikeda K
Rinsho Shinkeigaku; 1999 Dec; 39(12):1253-5. PubMed ID: 10791091
[TBL] [Abstract][Full Text] [Related]
13. Drug therapy for amyotrophic lateral sclerosis: Where are we now?
Carter GT; Krivickas LS; Weydt P; Weiss MD; Miller RG
IDrugs; 2003 Feb; 6(2):147-53. PubMed ID: 12789618
[TBL] [Abstract][Full Text] [Related]
14. Developments in treatments for amyotrophic lateral sclerosis via intracerebroventricular or intrathecal delivery.
Van Damme P; Robberecht W
Expert Opin Investig Drugs; 2014 Jul; 23(7):955-63. PubMed ID: 24816247
[TBL] [Abstract][Full Text] [Related]
15. Strategies for clinical approach to neurodegeneration in Amyotrophic lateral sclerosis.
Carlesi C; Pasquali L; Piazza S; Lo Gerfo A; Caldarazzo Ienco E; Alessi R; Fornai F; Siciliano G
Arch Ital Biol; 2011 Mar; 149(1):151-67. PubMed ID: 21412722
[TBL] [Abstract][Full Text] [Related]
16. [What are the etiological medical therapies in amyotrophic lateral sclerosis?].
Dib M
Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S215-4S219. PubMed ID: 17128114
[TBL] [Abstract][Full Text] [Related]
17. Motor neuron disease: systematic reviews of treatment for ALS and SMA.
Orrell RW
Br Med Bull; 2010; 93():145-59. PubMed ID: 20015852
[TBL] [Abstract][Full Text] [Related]
18. [A strategy to develop effective ALS therapy].
Mitsumoto H
Brain Nerve; 2007 Apr; 59(4):383-91. PubMed ID: 17447525
[TBL] [Abstract][Full Text] [Related]
19. Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?
Mitsumoto H; Brooks BR; Silani V
Lancet Neurol; 2014 Nov; 13(11):1127-1138. PubMed ID: 25316019
[TBL] [Abstract][Full Text] [Related]
20. Current and prospective disease-modifying therapies for amyotrophic lateral sclerosis.
Morren JA; Galvez-Jimenez N
Expert Opin Investig Drugs; 2012 Mar; 21(3):297-320. PubMed ID: 22303913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
